1 / 27

Ketogenic diet

Minnesota Epilepsy Group, P.A. Ketogenic diet. Jason Doescher, MD Pediatric Neurology & Epilepsy Minnesota Epilepsy Group, PA Saint Paul, Minnesota 651.241.5290. Ketogenic diet. ADK (adenosine kinase stain) Li et al. J Clin Invest. 2008;118(2):571–582. Discussion goals:

chacha
Download Presentation

Ketogenic diet

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Minnesota Epilepsy Group, P.A. Ketogenic diet Jason Doescher, MD Pediatric Neurology & Epilepsy Minnesota Epilepsy Group, PA Saint Paul, Minnesota 651.241.5290

  2. Ketogenic diet ADK (adenosine kinase stain) Li et al. J Clin Invest. 2008;118(2):571–582. Discussion goals: • Why: ketogenic diet in epilepsy therapy • What: ketogenic diet mechanism • Who: syndrome & seizure types • Where does it get you: results • How: strategy for tolerance & goals

  3. Understand pathology / understand diverse therapy Seizure: abnormal neuronal & inter-neuron connections leading to recurrent imbalance in excitation & inhibition altering normal function & signaling Molecular: Genes  proteins, neurotransmitters; toxins, electrolytes, energy/metabolism Cellular: Channels, receptors; neurons, astroglia Neuronal networks: Malformations of cortical development, inflammation, neoplasia, mesial temporal sclerosis/gliosis, trauma

  4. Minnesota Epilepsy Group, P.A. Therapeutic strategy:think pathology & review results

  5. Minnesota Epilepsy Group, P.A. AED efficacy: 64% total seizure free (301/470)Ref: Brodie & Kwan, NeurologyVol 58, Number 8, April 23, 2002 Monotherapy 1st AED Monotherapy 2nd AED Monotherapy 3rd AED Adjunctive Therapy Seizure-free 47% (n=221) Newly Diagnosed Epilepsy (n=470) Seizure-free 13% (n=32) Seizure-free 1% (n=1) Seizure-free 3% (n=1) Uncontrolled Seizures 53% (n=245) Uncontrolled Seizures 40% (n=100) Uncontrolled Seizures 39% (n=39) Uncontrolled Seizures 36% (n=14)

  6. Minnesota Epilepsy Group, P.A. Ketogenic diet: place in therapy • Anti-epileptic medications provide approximately 60-75% of patient’s with seizure control • If patient fails 3 medication trials, only 1-15% will achieve seizure control with additional medication combinations • Surgery: 50-90% of appropriate epileptogenic zone resection candidates attain seizure control, but only 5-15% total qualify

  7. KETOGENIC DIET

  8. Metabolism map

  9. Metabolism review:Typical diet: glucose  pyruvate acetyl CoA Ketogenic diet: fatty acid  acetyl CoA

  10. Minnesota Epilepsy Group, P.A. Mitochondria uses ‘citric acid cycle’ to make ATP. Acetyl CoA is common substrate of both fatty acid & glucose metabolism.

  11. Minnesota Epilepsy Group, P.A. Ketogenic diet • ‘transition of energy production from carbohydrates to fats’ • Effectiveness depends on the degree of carbohydrate restriction & maintenance of ketone level (BHB goal 3-4) • Fat: carbohydrate + protein ratio of 3:1 - 4:1 • 3:1 diet has long-chain saturated fat (87% calories), carbohydrate (6%), protein (7%)

  12. Ketogenic diet • Mechanism of action: metabolism v anti-epileptic properties of ketones/fatty acid metabolites • Ex. Neurosteroids on GABA-a receptors • Ref: Benaroch EE. Neurology 2007;68(8):612-614.

  13. Ketogenic diet: therapy

  14. Minnesota Epilepsy Group, P.A. Seizure & syndrome types:typically responsive to ketogenic diet Seizure types: Syndromes: Myoclonic atonic epilepsy Doose syndrome Lennox-Gastaut syndrome Glucose transporter deficiency syndrome Pyruvate dehydrogenase deficiency Metabolic/mitochondrial encephalopathies Caution to exclude fatty oxidation disorder Intractable focal or generalized epilepsy Dravet syndrome • Atypical absence (refractory) • Atonic • myoclonic atonic * • Tonic • Myoclonic

  15. Ketogenic diet: results

  16. Minnesota Epilepsy Group, P.A. Ketogenic diet: results • In 1923, Conklin treated epilepsy by prescribing “rest of gastrointestinal system” for 25 days. He reported 90% ‘success’ rate in children and 50% in adults. • In 1921, Wilder introduced the ketogenic diet. Later reported 95% of patients showing improvement through treatment.

  17. Minnesota Epilepsy Group, P.A. Ketogenic diet: results • Maydell (2001 USA): classic diet 4:1 ratio over 12 months, 143 patients • Seizure free: 16% • >90% seizure reduction: 27% • >50% seizure reduction: 38% • Kang (2005 Korea): 199 patients • Seizure free: 25% • >50% seizure reduction: 41%

  18. Minnesota Epilepsy Group, P.A. Ketogenic diet: results • In children, composite of many studies… Seizure free at 6 months 15% >90% seizure control: 37% 90-50% seizure control: 30% <50% seizure control: 33% • Keene 2006 meta-analysis

  19. EEG : before ketogenic diet

  20. EEG : before ketogenic diet

  21. Normal EEG : after ketogenic diet

  22. Minnesota Epilepsy Group, P.A. Keys to success: patience, consistency & teamwork Team • Dietician • Parent/Caregiver • Patient • G-Tube possible • Physician/Nurse

  23. Minnesota Epilepsy Group, P.A. Ketogenic Diet: application • Careful patient selection: exclude fatty acid oxidation disorder • Lab: Carnitine & acyl-carnitine profiles; urine organic acids • Gradual introduction (5-7 days), no fasting, no fluid restriction • Ensure energy & growth • Follow acidosis, glucose, & electrolytes (Na) • Supplements: vitamins (D, B) & minerals (Calcium, Selenium, Zinc) • Caution: • Depakote (follow liver function & carnitine stores) • Acetazolamide, topiramate & zonisamide (acidosis & kidney stones) • “Syrups & Elixirs” – sugar/carbohydrates • KNOW THE CARBOHYDRATE CONTENT!! • ‘2 week honeymoon’ then advance ratio

  24. Minnesota Epilepsy Group, P.A. Risks & complications • Growth delay & reduction • Hyperlipidemia • Cardiac dysfunction • Kidney stones • Disordered bone metabolism • Bone marrow dysfunction • Liver dysfunction

  25. Minnesota Epilepsy Group, P.A. Alternatives • Modified atkins diet • Low glycemic index diet

  26. Minnesota Epilepsy Group, P.A. Ketogenic diet • Why: role ketogenic diet in epilepsy therapy • Roughly 1 in 4 patients need new strategy beyond medications & surgery • What: ketogenic diet mechanism • Shift in energy metabolism with direct or indirect anti-epileptogenic properties • Who: syndrome & seizure types • Select patients & others who fail medication trials or who are not surgical candidates • Where does it get you: results • 15% seizure freedom, 30% excellent results, 30% modest improvement • How: strategy for tolerance & goals • Patience, consistency & teamwork

  27. Thank You Jason Doescher, MD Pediatric Neurology & Epilepsy Minnesota Epilepsy Group, PA Saint Paul, Minnesota 651.241.5290 Minnesota Epilepsy Group

More Related